시장보고서
상품코드
1309696

세계의 헬리코박터 파일로리 진단 시장 규모, 점유율, 산업 동향 분석 보고서 : 검사 유형별(비침습성, 침습성), 최종 사용자별, 방법별, 지역별 전망과 예측(2023-2030년)

Global Helicobacter Pylori Diagnostics Market Size, Share & Industry Trends Analysis Report By Test Type (Non-invasive and Invasive), By End User, By Method (Laboratory Based Test and Point of Care Test), By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 192 Pages | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 헬리코박터 파일로리 진단(Helicobacter Pylori Diagnostics) 시장 규모는 2030년 8억 590만 달러에 이를 것으로 예측되며, 5.5%의 CAGR 규모로 성장하여 상승할 전망입니다.

검사 유형별 전망

시장은 검사 유형별 비침습적 검사와 침습적 검사로 구분됩니다. 2022년 비침습적 검사 분야가 가장 큰 수익 점유율을 획득하여 시장을 독점했습니다. 이는 침습적 검사에 비해 많은 이점이 있는 것과 비침습적 검사법 진보, H. pylori 위염과 관련된 위궤양 발생률 증가 등으로 인해 비침습적 진단이 점점 대중화되고 있기 때문입니다. 비침습적 진단법 중 일부는 소변 호기시험이나 대변 항원 시험과 같이 활발하게 퍼져 있는 질병을 특정할 수 있는 것도「능동적 검사」라고 불리고 있습니다. 1차 케어는 비침습적인 검사 및 치료 전략을 적극 권장합니다.

검사법 전망

검사법별로는, 시장은 검사실 기반 검사법과 포인트 오브 케어 검사법으로 나눌 수 있습니다. 2022년 시장은 실험실 기반 검사 분야가 가장 큰 수익 점유율을 차지하고 있습니다. 이는 정확성, 사용 용이성, 접근성 용이성으로 인한 것이며, 면역분석과 같은 실험실 기반 검사는 채용률이 높습니다. 안전한 배송을 보장하기 위해 임상의는 환자로부터 샘플을 채취하고 포장합니다. 이 샘플은 중앙 연구소로 보내지며, 기술자가 처리합니다. 실험실 검사 결과는 복잡성에 따라 다르지만 일반적으로 1-2일 이내에 작성되고 보고서가 개업자에게 반송합니다.

최종 사용자, 전망

최종 사용자별 시장은 진단 실험실, 병원 등으로 분류됩니다. 병원 부문은 2022년 시장에서 큰 판매 점유율을 기록했습니다. 이 부문은 의사가 접근하기 쉽고 질병이 쉽게 제시될 수 있으며 소장 감염, 위암, 위염, 십이지장 궤양 및 위궤양과 같은 질병 발생이 증가한 결과입니다. 또한 병원은 적절한 치료와 진단을 보장하는 최첨단 기술과 직원을 보유하고 있는 것으로 알려져 있으며, 이는 시장 부문의 성장을 뒷받침하고 있습니다.

지역별 전망

지역별로 시장은 북미, 유럽, 아시아태평양, LAMEA로 구분됩니다. 북미는 2022년 가장 큰 수익 점유율을 창출하고 시장을 선도했습니다. 이는 북미 헬스케어 지출이 가장 크고 파일로리균 검사를 위한 진단 검사에 접근하기 쉽기 때문입니다. 견고한 건강 관리 인프라, 높은 구매력, 헬리코박터 파일로리 진단 검사 사용 증가가 시장 확대를 촉진할 것으로 예상됩니다. 또한 주요 지역 경쟁 업체들이 제품 승인, 인수, 계약을 통해 시장을 끌어올려 시장에 추가 성장 기회를 제공합니다.

목차

제1장 시장 범위와 조사 방법

  • 시장 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 주요 요약

  • 소개
    • 주요 요약
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진 요인
    • 시장 성장 억제 요인

제3장 세계의 헬리코박터 파일로리 진단 시장 : 검사 유형별

  • 세계의 비침습적 시장 : 지역별
  • 세계의 침략적 시장 : 지역별

제4장 세계의 헬리코박터 파일로리 진단 시장 : 최종 사용자별

  • 세계의 진단 실험실 시장 : 지역별
  • 세계의 병원 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제5장 세계의 헬리코박터 파일로리 진단 시장 : 방법별

  • 세계의 검사실 베이스 시장 : 지역별
  • 세계의 포인트 오브 케어 검사 시장 : 지역별

제6장 세계의 헬리코박터 파일로리 진단 시장 : 지역별

  • 북미
    • 북미 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아태평양
    • 아시아태평양 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카, 중동, 아프리카
    • 라틴아메리카, 중동, 아프리카 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카
      • 나이지리아
      • 기타 라틴아메리카, 중동, 아프리카

제7장 기업 프로필

  • Biohit Oyj
  • Gulf Coast Scientific, Inc(Gulf Coast Medical Center)
  • Meridian Bioscience, Inc(SD Biosensor Co., Ltd.)
  • Avanos Medical, Inc
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • F Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Cardinal Health, Inc
  • Bio-Rad laboratories, Inc
NJH 23.08.24

The Global Helicobacter Pylori Diagnostics Market size is expected to reach $805.9 Million by 2030, rising at a market growth of 5.5% CAGR during the forecast period.

Diagnostic Laboratories are emerging rapidly due to the rising need for diagnosis of various diseases. Therefore, the diagnostic laboratories segment is expected to generate more than 57% share of the market by 2029. H. pylori infection is responsible for about 89% of all cases of gastric cancer, thus, the need for diagnosis emerges. For example, Gastric cancer will cause 770,000 deaths and 1.1 million new cases worldwide 2020. With variations among nations, male and female incidence rates were, on average, two times higher (15.8 and 7.0 per 100,000, respectively). The highest incidence rates were found in Eastern Asia for both males and females (32.5 and 13.2, respectively); the highest rates were found for males living in Japan (48.1), Mongolia (47.2), and Korea (39.7). With incidence rates of under 5 per 100,000, Africa had the lowest incidence. Some of the factors impacting the market are infectious illness prevalence is increasing, creation of novel and enhanced testing techniques, and limitations of diagnostic methods.

In many nations in 2020, taking a flight across international borders is as commonplace as taking a bus or rail to another city. It is incredibly challenging to stop the spread of many diseases since air travel makes it feasible for someone to fly halfway around the world in less time than it takes for many infections to incubate. As a result, the mentioned reasons are raising the incidence of infectious disorders like helicobacter pylori, raising the demand for diagnosis, and supporting market growth. A biosensor is created to pair a transducer and a bioreceptor, which transforms biological activity into a quantifiable signal. Based on the recognition process, the bio-detection systems are categorized into bio-catalytic or bio-affinity-based systems. The need for these diagnosis techniques will rise due to this advancement in diagnosing helicobacter pylori, driving the market's expansion.

However, some organisms (Brucella and H. pylori) split urea quickly, while others react slowly. Thus, for complete identification, it is recommended that biochemical and serological tests be undertaken on pure culture colonies. Inoculum from a bouillon suspension should not be used to promote growth and the urea hydrolysis reaction. Thus, the limitations associated with various diagnostic methods of helicobacter pylori are expected to hinder market growth.

The pandemic has caused non-urgent diagnostic procedures, such as H. pylori tests, to be delayed or abandoned. As a result, there has been a drop in the demand for H. pylori testing, which has impacted the earnings of businesses involved in this market. However, after the pandemic, the market begin to stabilize and show steady growth for the market. The availability of efficient treatment options for H. pylori infection and the development of novel, reasonably priced diagnostic technologies are credited with this. These factors are anticipated to propel the expansion of the H. pylori diagnostics market in the upcoming years.

Test Type Outlook

Based on test type, the market is segmented into non-invasive test and invasive test. The non-invasive test segment dominated the market with maximum revenue share in 2022. This is due to its many advantages over invasive tests, the advancement of non-invasive testing methods, and the rise in the incidence of stomach ulcers linked to H. pylori gastritis, non-invasive diagnostics have become more and more popular. Some non-invasive diagnostics, referred to as "active tests," can identify an illness that is actively spreading, such as the urea breath test and the stool antigen test. In the primary care context, non-invasive test-and-treat strategies are strongly advised.

Method Outlook

On the basis of method, the market is divided into laboratory-based test and point of care test. The laboratory-based test segment witnessed the largest revenue share in the market in 2022. This is owing to their accuracy, usability, and accessibility; laboratory-based tests like the immunoassay have a high adoption rate. To ensure safe shipping, the clinician collects and packages a sample from the patient. This sample is sent to a central lab where a technician will process it. Results from lab tests can typically be generated within 1-2 days, depending on their complexity, and a report is returned to the practitioner.

End User Outlook

By end user, the market is classified into diagnostics laboratories, hospitals and others. The hospitals segment recorded a significant revenue share in the market in 2022. The segment growth is the result of the accessibility of doctors, the ease with which ailments can be presented, and the growing occurrence of conditions, including small intestinal infections, stomach cancer, gastritis, and duodenal and gastric ulcers. Also, hospitals are known for having cutting-edge technology and staff that guarantee adequate care and diagnosis, which is aiding the market segment to grow in the projected period.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the market by generating the maximum revenue share in 2022. This is because the biggest healthcare spending is in North America, which facilitates easier access to diagnostic tests for H pylori testing. A robust healthcare infrastructure, high purchasing power, and increased usage of helicobacter pylori diagnostic tests are anticipated to fuel market expansion. Additionally, the market is boosted by product approvals, acquisitions, and agreements made by the major regional competitors, providing more growth opportunities for the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Biohit Oyj, Abbott Laboratories, Quidel Corporation, Gulf Coast Scientific, Inc. (Gulf Coast Medical Center), Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Avanos Medical, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments covered in the Report:

By Test Type

  • Non-invasive
  • Invasive

By End User

  • Diagnostics Laboratories
  • Hospitals
  • Others

By Method

  • Laboratory Based Test
  • Point of Care Test

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Cardinal Health, Inc.
  • Biohit Oyj
  • Abbott Laboratories
  • Quidel Corporation
  • Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
  • Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
  • Avanos Medical, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Helicobacter Pylori Diagnostics Market, by Test Type
    • 1.4.2 Global Helicobacter Pylori Diagnostics Market, by End User
    • 1.4.3 Global Helicobacter Pylori Diagnostics Market, by Method
    • 1.4.4 Global Helicobacter Pylori Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Helicobacter Pylori Diagnostics Market by Test Type

  • 3.1 Global Non-invasive Market by Region
  • 3.2 Global Invasive Market by Region

Chapter 4. Global Helicobacter Pylori Diagnostics Market by End User

  • 4.1 Global Diagnostics Laboratories Market by Region
  • 4.2 Global Hospitals Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Helicobacter Pylori Diagnostics Market by Method

  • 5.1 Global Laboratory Based Test Market by Region
  • 5.2 Global Point of Care Test Market by Region

Chapter 6. Global Helicobacter Pylori Diagnostics Market by Region

  • 6.1 North America Helicobacter Pylori Diagnostics Market
    • 6.1.1 North America Helicobacter Pylori Diagnostics Market by Test Type
      • 6.1.1.1 North America Non-invasive Market by Country
      • 6.1.1.2 North America Invasive Market by Country
    • 6.1.2 North America Helicobacter Pylori Diagnostics Market by End User
      • 6.1.2.1 North America Diagnostics Laboratories Market by Country
      • 6.1.2.2 North America Hospitals Market by Country
      • 6.1.2.3 North America Others Market by Country
    • 6.1.3 North America Helicobacter Pylori Diagnostics Market by Method
      • 6.1.3.1 North America Laboratory Based Test Market by Country
      • 6.1.3.2 North America Point of Care Test Market by Country
    • 6.1.4 North America Helicobacter Pylori Diagnostics Market by Country
      • 6.1.4.1 US Helicobacter Pylori Diagnostics Market
        • 6.1.4.1.1 US Helicobacter Pylori Diagnostics Market by Test Type
        • 6.1.4.1.2 US Helicobacter Pylori Diagnostics Market by End User
        • 6.1.4.1.3 US Helicobacter Pylori Diagnostics Market by Method
      • 6.1.4.2 Canada Helicobacter Pylori Diagnostics Market
        • 6.1.4.2.1 Canada Helicobacter Pylori Diagnostics Market by Test Type
        • 6.1.4.2.2 Canada Helicobacter Pylori Diagnostics Market by End User
        • 6.1.4.2.3 Canada Helicobacter Pylori Diagnostics Market by Method
      • 6.1.4.3 Mexico Helicobacter Pylori Diagnostics Market
        • 6.1.4.3.1 Mexico Helicobacter Pylori Diagnostics Market by Test Type
        • 6.1.4.3.2 Mexico Helicobacter Pylori Diagnostics Market by End User
        • 6.1.4.3.3 Mexico Helicobacter Pylori Diagnostics Market by Method
      • 6.1.4.4 Rest of North America Helicobacter Pylori Diagnostics Market
        • 6.1.4.4.1 Rest of North America Helicobacter Pylori Diagnostics Market by Test Type
        • 6.1.4.4.2 Rest of North America Helicobacter Pylori Diagnostics Market by End User
        • 6.1.4.4.3 Rest of North America Helicobacter Pylori Diagnostics Market by Method
  • 6.2 Europe Helicobacter Pylori Diagnostics Market
    • 6.2.1 Europe Helicobacter Pylori Diagnostics Market by Test Type
      • 6.2.1.1 Europe Non-invasive Market by Country
      • 6.2.1.2 Europe Invasive Market by Country
    • 6.2.2 Europe Helicobacter Pylori Diagnostics Market by End User
      • 6.2.2.1 Europe Diagnostics Laboratories Market by Country
      • 6.2.2.2 Europe Hospitals Market by Country
      • 6.2.2.3 Europe Others Market by Country
    • 6.2.3 Europe Helicobacter Pylori Diagnostics Market by Method
      • 6.2.3.1 Europe Laboratory Based Test Market by Country
      • 6.2.3.2 Europe Point of Care Test Market by Country
    • 6.2.4 Europe Helicobacter Pylori Diagnostics Market by Country
      • 6.2.4.1 Germany Helicobacter Pylori Diagnostics Market
        • 6.2.4.1.1 Germany Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.1.2 Germany Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.1.3 Germany Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.2 UK Helicobacter Pylori Diagnostics Market
        • 6.2.4.2.1 UK Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.2.2 UK Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.2.3 UK Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.3 France Helicobacter Pylori Diagnostics Market
        • 6.2.4.3.1 France Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.3.2 France Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.3.3 France Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.4 Russia Helicobacter Pylori Diagnostics Market
        • 6.2.4.4.1 Russia Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.4.2 Russia Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.4.3 Russia Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.5 Spain Helicobacter Pylori Diagnostics Market
        • 6.2.4.5.1 Spain Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.5.2 Spain Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.5.3 Spain Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.6 Italy Helicobacter Pylori Diagnostics Market
        • 6.2.4.6.1 Italy Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.6.2 Italy Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.6.3 Italy Helicobacter Pylori Diagnostics Market by Method
      • 6.2.4.7 Rest of Europe Helicobacter Pylori Diagnostics Market
        • 6.2.4.7.1 Rest of Europe Helicobacter Pylori Diagnostics Market by Test Type
        • 6.2.4.7.2 Rest of Europe Helicobacter Pylori Diagnostics Market by End User
        • 6.2.4.7.3 Rest of Europe Helicobacter Pylori Diagnostics Market by Method
  • 6.3 Asia Pacific Helicobacter Pylori Diagnostics Market
    • 6.3.1 Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type
      • 6.3.1.1 Asia Pacific Non-invasive Market by Country
      • 6.3.1.2 Asia Pacific Invasive Market by Country
    • 6.3.2 Asia Pacific Helicobacter Pylori Diagnostics Market by End User
      • 6.3.2.1 Asia Pacific Diagnostics Laboratories Market by Country
      • 6.3.2.2 Asia Pacific Hospitals Market by Country
      • 6.3.2.3 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Helicobacter Pylori Diagnostics Market by Method
      • 6.3.3.1 Asia Pacific Laboratory Based Test Market by Country
      • 6.3.3.2 Asia Pacific Point of Care Test Market by Country
    • 6.3.4 Asia Pacific Helicobacter Pylori Diagnostics Market by Country
      • 6.3.4.1 China Helicobacter Pylori Diagnostics Market
        • 6.3.4.1.1 China Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.1.2 China Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.1.3 China Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.2 Japan Helicobacter Pylori Diagnostics Market
        • 6.3.4.2.1 Japan Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.2.2 Japan Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.2.3 Japan Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.3 India Helicobacter Pylori Diagnostics Market
        • 6.3.4.3.1 India Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.3.2 India Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.3.3 India Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.4 South Korea Helicobacter Pylori Diagnostics Market
        • 6.3.4.4.1 South Korea Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.4.2 South Korea Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.4.3 South Korea Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.5 Singapore Helicobacter Pylori Diagnostics Market
        • 6.3.4.5.1 Singapore Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.5.2 Singapore Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.5.3 Singapore Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.6 Malaysia Helicobacter Pylori Diagnostics Market
        • 6.3.4.6.1 Malaysia Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.6.2 Malaysia Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.6.3 Malaysia Helicobacter Pylori Diagnostics Market by Method
      • 6.3.4.7 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market
        • 6.3.4.7.1 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type
        • 6.3.4.7.2 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by End User
        • 6.3.4.7.3 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Method
  • 6.4 LAMEA Helicobacter Pylori Diagnostics Market
    • 6.4.1 LAMEA Helicobacter Pylori Diagnostics Market by Test Type
      • 6.4.1.1 LAMEA Non-invasive Market by Country
      • 6.4.1.2 LAMEA Invasive Market by Country
    • 6.4.2 LAMEA Helicobacter Pylori Diagnostics Market by End User
      • 6.4.2.1 LAMEA Diagnostics Laboratories Market by Country
      • 6.4.2.2 LAMEA Hospitals Market by Country
      • 6.4.2.3 LAMEA Others Market by Country
    • 6.4.3 LAMEA Helicobacter Pylori Diagnostics Market by Method
      • 6.4.3.1 LAMEA Laboratory Based Test Market by Country
      • 6.4.3.2 LAMEA Point of Care Test Market by Country
    • 6.4.4 LAMEA Helicobacter Pylori Diagnostics Market by Country
      • 6.4.4.1 Brazil Helicobacter Pylori Diagnostics Market
        • 6.4.4.1.1 Brazil Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.1.2 Brazil Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.1.3 Brazil Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.2 Argentina Helicobacter Pylori Diagnostics Market
        • 6.4.4.2.1 Argentina Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.2.2 Argentina Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.2.3 Argentina Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.3 UAE Helicobacter Pylori Diagnostics Market
        • 6.4.4.3.1 UAE Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.3.2 UAE Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.3.3 UAE Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.4 Saudi Arabia Helicobacter Pylori Diagnostics Market
        • 6.4.4.4.1 Saudi Arabia Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.4.2 Saudi Arabia Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.4.3 Saudi Arabia Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.5 South Africa Helicobacter Pylori Diagnostics Market
        • 6.4.4.5.1 South Africa Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.5.2 South Africa Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.5.3 South Africa Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.6 Nigeria Helicobacter Pylori Diagnostics Market
        • 6.4.4.6.1 Nigeria Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.6.2 Nigeria Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.6.3 Nigeria Helicobacter Pylori Diagnostics Market by Method
      • 6.4.4.7 Rest of LAMEA Helicobacter Pylori Diagnostics Market
        • 6.4.4.7.1 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Test Type
        • 6.4.4.7.2 Rest of LAMEA Helicobacter Pylori Diagnostics Market by End User
        • 6.4.4.7.3 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Method

Chapter 7. Company Profiles

  • 7.1 Biohit Oyj
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expenses
  • 7.2 Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
    • 7.2.1 Company Overview
  • 7.3 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Recent strategies and developments:
      • 7.3.3.1 Acquisition and Mergers:
  • 7.4 Avanos Medical, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 Abbott Laboratories
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 SWOT Analysis
  • 7.6 Thermo Fisher Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 F. Hoffmann-La Roche Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Quidel Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Cardinal Health, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
  • 7.10. Bio-Rad laboratories, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제